Kite Pharma, Inc. (KITE) |
---|
$39.82 52 Week Low | $82.08 2017-04-28 15:02:48 MDT | $88.58 52 Week High |
Healthcare Sector | Biotechnology Industry |
Nasdaq Stock Exchange | United States Country |
Market Cap: | $4,510,000,000 | Mid Cap (Between $2B and $10B) |
Analyst Recommendation: | 2.1 | Analysts say: Buy. (1=Strong Buy, 5=Strong Sell) |
Beta: | N/A | Unknown Beta. A beta of 1 means that stock will go up or down at the same rate as the S&P 500 index. |
ForwardPE: Unknown | 5 Yr Est Growth: Unknown | Yield: 0.00% |
PEG-Y Ratio: N/A | Unknown PEG-Y ratio |
% Above 50 DayMA: 3.34% | % Above 200 DayMA: 41.49% |
KITE Performance 52 Weeks: 73.82% | S&P 500 Performance 52 Weeks: 12.50% |
Uptrend is still intact: KITE is above both 50 and 200 day Moving Averages. There is hope because 50 Day MA is still above 200 Day MA. Stock is closer to 52 Week High than 52 Week Low. | KITE outperforming S&P 500 by 61.32% the last 52 Weeks. |
Price To Book: 9.3 | OK Value. Low Price to Book means better value. A P/B value of 5 or less is great. |
EV to EBITDA: -13.66 | Unknown EV to EBITDA ratio |
Field | Value | Average | Comments |
---|---|---|---|
% Held By Insiders | 30.86% | 17.28% | Held by greater than average Insiders. Insiders can sway stock price. Watch insider buying and selling. |
% Held By Institutions | 68.40% | 62.07% | Institutional percentage greater than average. Institutional buying and selling can really move stock price. |
Short % Of Float | 26.88% | 07.02% | Shorted by greater than average percent. Investors and traders do not believe in stock. But watch out for short squeezes pushing stock upwards. |
Debt to Equity | N/A | 1.08 | Unknown. |
Profit Margin % | N/A | -00.18% | Unknown. |
Operating Margin % | -1.00% | -05.28% | Operating Margin greater than average percent. Good. |
Return on Equity % | -51.18% | -08.79% | Return on Equity less than average percent. Stock can do better than this? |
Return on Assets % | -27.63% | -01.29% | Return on Assets less than average percent. Stock can do better than this? |
Revenue Per Employee | $49,597.32 | $883,096.70 | Less than average Revenue Per Employee. This stock (or industry) might not be as efficient as others? Each industry might have a different standard. |
Price to Cash | 9.94 | 5.52 | Higher than average Price to Cash. Meaning that the company has a lower percentage of cash as a percent of price. Cash can be good to cushion company during hard times, and as a potential source for buyouts or investments. However, some activists want the cash to be used by a company to buy its own stock, or to increase their dividend, or to invest the money. |
CPEGY Ratio | N/A | 2.26 | Unknown. |
PROS:
| CONS:
|